This report on the global continence care market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031.
The report provides the overall revenue of the global continence care market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global continence care market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global continence care market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global continence care market.
The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global continence care market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global continence care market. The next section of the continence care market report highlights the USPs, which includes, COVID-19 pandemic impact on industry (value chain and short/mid/long term impact), technological advancements, pricing analysis, reimbursement scenario by region/globally, key industrial events (licensing partnership/merger & acquisition), and Porter's five force analysis.
The report delves into the competition landscape of the global continence care market. Key players operating in the global continence care market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the continence care market in report.
Key Questions Answered in Continence Care Market Report
What are the sales/revenue generated by continence care across the globe during the forecast period?
What are the key trends in the global continence care market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue in 2031 and which segment will grow at the highest CAGR during the forecast period?
Which is the most attractive market in terms of product type, indication, end-user, and region during 2021-2031?
Key Topics Covered:
1. Preface
2. Assumptions and Research Methodology
3. Executive Summary: Global Continence Care Market
6. Global Continence Care Market Analysis and Forecast, by Product Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Product Type, 2017-2031 6.3.1. Urinary Catheters 6.3.1.1. External Catheters 6.3.1.2. Indwelling Catheters 6.3.1.3. Intermittent Catheters 6.3.1.4. Catheter Accessories 6.3.2. Male Bodyworn Urinals 6.3.3. Mechanical Devices for Women with Urinary Incontinence 6.3.3.1. Urethral Inserts 6.3.3.2. Intravaginal Devices 6.3.4. Urine Drainage Bags & Accessories 6.3.4.1. Leg Drainage Bags 6.3.4.2. Night Drainage Bags 6.3.4.3. Accessories 6.3.5. Absorbents 6.3.6. Penile Clamps 6.3.7. Non-implantable Electrical Stimulation Devices 6.3.8. Others 6.4. Market Attractiveness Analysis, by Product Type
7. Global Continence Care Market Analysis and Forecast, by Indication 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Indication, 2017-2031 7.3.1. Urge Urinary Incontinence (UUI) 7.3.2. Stress Urinary Incontinence (SUI) 7.3.3. Mixed Urinary Incontinence (MUI) 7.3.4. Others 7.4. Market Attractiveness Analysis, by Indication
8. Global Continence Care Market Analysis and Forecast, by End-user 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by End-user, 2017-2031 8.3.1. Acute Care Facilities 8.3.2. Long Term Care Facilities 8.3.3. Homecare 8.3.4. Others 8.4. Market Attractiveness Analysis, by End-user
9. Global Continence Care Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Country/Region
10. North America Continence Care Market Analysis and Forecast
11. Europe Continence Care Market Analysis and Forecast
12. Asia Pacific Continence Care Market Analysis and Forecast
13. Latin America Continence Care Market Analysis and Forecast
14. Middle East & Africa Continence Care Market Analysis and Forecast
15. Competitive Landscape 15.1. Market Share Analysis of Key Companies, by Region (2020) 15.2. Company Profiles 15.2.1. Abena A/S 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.1.2. Product Portfolio 15.2.1.3. Strategic Overview 15.2.1.4. SWOT Analysis 15.2.2. Atlantic Therapeutics 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2.2. Product Portfolio 15.2.2.3. Strategic Overview 15.2.2.4. SWOT Analysis 15.2.3. Attends Healthcare Products, Inc. 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.3.2. Product Portfolio 15.2.3.3. Strategic Overview 15.2.3.4. SWOT Analysis 15.2.4. B. Braun Melsungen AG 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.4.2. Product Portfolio 15.2.4.3. Financial Overview 15.2.4.4. Strategic Overview 15.2.4.5. SWOT Analysis 15.2.5. Beambridge Medical Ltd. 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.5.2. Product Portfolio 15.2.5.3. Strategic Overview 15.2.5.4. SWOT Analysis 15.2.6. Becton, Dickinson and Company 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.6.2. Product Portfolio 15.2.6.3. Financial Overview 15.2.6.4. Strategic Overview 15.2.6.5. SWOT Analysis 15.2.7. Boston Scientific Corporation 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.7.2. Product Portfolio 15.2.7.3. Strategic Overview 15.2.7.4. SWOT Analysis 15.2.8. Coloplast A/S 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.8.2. Product Portfolio 15.2.8.3. Financial Overview 15.2.8.4. Strategic Overview 15.2.8.5. SWOT Analysis 15.2.9. ConvaTec Group PLC 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.9.2. Product Portfolio 15.2.9.3. Financial Overview 15.2.9.4. Strategic Overview 15.2.9.5. SWOT Analysis 15.2.10. Drylock Technologies 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.10.2. Product Portfolio 15.2.10.3. Strategic Overview 15.2.10.4. SWOT Analysis 15.2.11. Hollister Incorporated 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.11.2. Product Portfolio 15.2.11.3. Strategic Overview 15.2.11.4. SWOT Analysis 15.2.12. InControl Medical LLC 15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.12.2. Product Portfolio 15.2.12.3. Strategic Overview 15.2.12.4. SWOT Analysis 15.2.13. Kimberly-Clark Corporation 15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.13.2. Product Portfolio 15.2.13.3. Financial Overview 15.2.13.4. Strategic Overview 15.2.13.5. SWOT Analysis 15.2.14. Optimum Medical Limited 15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.14.2. Product Portfolio 15.2.14.3. Strategic Overview 15.2.14.4. SWOT Analysis 15.2.15. Pacey MedTech Ltd. 15.2.15.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.15.2. Product Portfolio 15.2.15.3. Strategic Overview 15.2.15.4. SWOT Analysis 15.2.16. Renew Medical, Inc. 15.2.16.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.16.2. Product Portfolio 15.2.16.3. Strategic Overview 15.2.16.4. SWOT Analysis 15.2.17. Uresta 15.2.17.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.17.2. Product Portfolio 15.2.17.3. Strategic Overview 15.2.17.4. SWOT Analysis 15.2.18. Urocare Products, Inc. 15.2.18.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.18.2. Product Portfolio 15.2.18.3. Strategic Overview 15.2.18.4. SWOT Analysis 15.2.19. Vesiflo, Inc. 15.2.19.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.19.2. Product Portfolio 15.2.19.3. Strategic Overview 15.2.19.4. SWOT Analysis
